The global CVD burden is expected to see a 3.6% year-on-year increase from 2025 to 2050 [5], thus emphasizing the need for effective strategies in cardiometabolic prevention within the global health conundrum [6,7,8,9]
Unlike oral supplements, our System Reboot IV bypasses the digestive system, allowing for rapid absorption of vital nutrients
Moreover, pods are advised for the treatment of dysentery, gonorrhea, and urinary problems
It is interesting to note that an open, uncontrolled, multicenter study involving 43 centers focused on 636 IBS constipation-predominant patients who were given a synbiotic composed of Bifidobacterium longum W11 and the short chain oligosaccharide prebiotic Fos Actilight, had reported significant improvements in stool frequency, bloating and abdominal pain ( Bifidobacterium lactis was associated with significant improvement on IBS symptoms and bowel habit vs